Influence of pre-exposure to morphine on cannabinoid-induced impairment of spatial memory in male rats

Behavioural Brain Research

Volumn 256, Issue , 2013, Pages 157-164

  Farahmandfar, Maryam ^a,b   Kadivar, Mehdi ^c   Naghdi, Nasser ^c   Choopani, Samira ^c   Zarrindast, Mohammad Reza ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Acquisition; Cannabinoids; Dorsal Hippocampus; Opioids; Rat; Spatial memory

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; MORPHINE SULFATE; MU OPIATE RECEPTOR; NALOXONE; BENZOXAZINE DERIVATIVE; MORPHINE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; PSYCHOTROPIC AGENT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; LATENT PERIOD; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; VISUAL DISCRIMINATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; MEMORY DISORDERS; PATHOPHYSIOLOGY; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; TASK PERFORMANCE; TIME; VISION; WISTAR RAT;

ANIMALS; BENZOXAZINES; CA1 REGION, HIPPOCAMPAL; DISCRIMINATION (PSYCHOLOGY); MALE; MAZE LEARNING; MEMORY DISORDERS; MORPHINE; MORPHOLINES; NALOXONE; NAPHTHALENES; NARCOTIC ANTAGONISTS; NARCOTICS; PSYCHOTROPIC DRUGS; RATS, WISTAR; SPATIAL MEMORY; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS; VISUAL PERCEPTION;

EID: 84883364378     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.054     Document Type: Article

References (67)

1. Aigner T.G. Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys. Psychopharmacology (Berl) 1988, 95:507-511.
2. Belmore S.M., Miller L.L. Levels of processing and acute effects of marijuana on memory. Pharmacol Biochem Behav 1980, 13:199-203.
3. Berrendero F., Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 2002, 163:111-117.
4. Bhargava H.N. Multiple opiate receptors of brain and spinal cord in opiate addiction. Gen Pharmacol 1991, 22:767-772.
5. Bhargava H.N., Matwyshyn G.A. Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous locomotor activity and analgesia induced by delta 9-tetrahydrocannabinol in the mouse. Eur J Pharmacol 1980, 68:147-154.
6. Bloom A.S., Dewey W.L. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse. Psychopharmacology (Berl) 1978, 57:243-248.
7. Cadoni C., Pisanu A., Solinas M., Acquas E., Di Chiara G. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) 2001, 158:259-266.
8. Cadoni C., Valentini V., Di Chiara G. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem 2008, 106:1586-1593.
9. Cami J., Farre M. Drug addiction. N Engl J Med 2003, 349:975-986.
10. Chiu C.Q., Castillo P.E. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. Neuropharmacology 2008, 54:68-78.
11. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:321-325.
12. Darley C.F., Tinklenberg J.R., Hollister T.E., Atkinson R.C. Marihuana and retrieval from short-term memory. Psychopharmacologia 1973, 29:231-238.
13. de Oliveira Alvares L., de Oliveira L.F., Camboim C., Diehl F., Genro B.P., Lanziotti V.B., et al. Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiol Learn Mem 2005, 83:119-124.
14. De Querv ain D.J., Roozendaal B., McGaug h J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998, 394:787-790.
15. Dewey W.L. Cannabinoid pharmacology. Pharmacol Rev 1986, 38:151-178.
16. Di Marzo V., Bifulco M., De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 2004, 3:771-784.
17. Emrich H.M., Weber M.M., Wendl A., Zihl J., von Meyer L., Hanisch W. Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment. Pharmacol Biochem Behav 1991, 40:689-690.
18. Fan N., Yang H., Zhang J., Chen C. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. J Neurochem 2009, 112:691-702.
19. Farahmandfar M., Karimian S.M., Naghdi N., Zarrindast M.R., Kadivar M. Morphine-induced impairment of spatial memory acquisition reversed by morphine sensitization in rats. Behav Brain Res 2011, 211:156-163.
20. Farahmandfar M., Karimian S.M., Zarrindast M.R., Kadivar M., Afrouzi H., Naghdi N. Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via mu-opioid receptor. Neurosci Lett 2011, 494:130-134.
21. Farahmandfar M., Naghdi N., Karimian S.M., Kadivar M., Zarrindast M.R. Amnesia induced by morphine in spatial memory retrieval inhibited in morphine-sensitized rats. Eur J Pharmacol 2012, 683:132-139.
22. Farahmandfar M., Zarrindast M.R., Kadivar M., Karimian S.M., Naghdi N. The effect of morphine sensitization on extracellular concentrations of GABA in dorsal hippocampus of male rats. Eur J Pharmacol 2011, 669:66-70.
23. Ferrari F., Ottani A., Vivoli R., Giuliani D. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 1999, 64:555-561.
24. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
25. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 2002, 22:1146-1154.
26. Hajos N., Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids 2002, 121:73-82.
27. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 1993, 264:294-307.
28. Hollister L.E. Health aspects of cannabis. Pharmacol Rev 1986, 38:1-20.
29. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., et al. International Union of Pharmacology XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002, 54:161-202.
30. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695-703.
31. Iremonger K.J., Benediktsson A.M., Bains J.S. Glutamatergic synaptic transmission in neuroendocrine cells: basic principles and mechanisms of plasticity. Front Neuroendocrinol 2010, 31:296-306.
32. Jamali-Raeufy N., Nasehi M., Ebrahimi-Ghiri M., Zarrindast M.R. Cross state-dependency of learning between WIN55, 212-2 and scopolamine in rat dorsal hippocampus. Neurosci Lett 2011, 491:227-231.
33. Jentsch J.D., Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward- related stimuli. Psychopharmacology (Berl) 1999, 146:373-390.
34. Kornetsky C., Brain-stimulation reward morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev 2004, 27:777-786.
35. Kuribara H. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 1995, 275:251-258.
36. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
37. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl) 1995, 119:282-290.
38. Lichtman A.H., Martin B.R. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl) 1996, 126:125-131.
39. Maldonado R., Rodriguez de Fonseca F. Cannabinoid addiction: behavioral models and neural correlates. J Neurosci 2002, 22:3326-3331.
40. Martin B.R. Cellular effects of cannabinoids. Pharmacol Rev 1986, 38:45-74.
41. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 2000, 12:4038-4046.
42. Molina-Holgado F., Gonzalez M.I., Leret M.L. Effect of delta 9-tetrahydrocannabinol on short-term memory in the rat. Physiol Behav 1995, 57:177-179.
43. Moosavi M., Naghdi N., Maghsoudi N., Zahedi Asl S. Insulin protects against stress-induced impairments in water maze performance. Behav Brain Res 2007, 176:230-236.
44. Mukhopadhyay S., Shim J.Y., Assi A.A., Norford D., Howlett A.C. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem Phys Lipids 2002, 121:91-109.
45. Narimatsu S., Yamamoto I., Watanabe K., Yoshimura H. Change in hypothermia and catalepsy induced by cannabinoids or morphine in mice tolerant to these substances. Eur J Pharmacol 1987, 141:437-443.
46. Nowicky A.V., Teyler T.J., Vardaris R.M. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 1987, 19:663-672.
47. Ohno-Shosaku T., Hashimotodani Y., Ano M., Takeda S., Tsubokawa H., Kano M. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. J Physiol 2007, 584:407-418.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, UK: Academic Press, London.
49. Pertwee R.G. The central neuropharmacology of psychotropic cannabinoids. Pharmacol Ther 1988, 36:189-261.
50. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4:873-884.
51. Pontieri F.E., Monnazzi P., Scontrini A., Buttarelli F.R., Patacchioli F.R. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. Eur J Pharmacol 2001, 421:1-3.
52. Rice O.V., Gordon N., Gifford A.N. Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice. Brain Res 2002, 945:135-138.
53. Robinson L., McKillop-Smith S., Ross N.L., Pertwee R.G., Hampson R.E., Platt B., et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berl) 2008, 198:551-563.
54. Rubino T., Vigano D., Massi P., Parolaro D. The psychoactive ingredient of marijuana induces behavioural sensitization. Eur J Neurosci 2001, 14:884-886.
55. Sahraei H., Etemadi L., Rostami P., Pourmotabbed A., Zarrindast M.R., Shams J., et al. GABAB receptors within the ventral tegmental area are involved in the expression and acquisition of morphine-induced place preference in morphine-sensitized rats. Pharmacol Biochem Behav 2009, 91:409-416.
56. Serrano A., Aguilar M.A., Manzanedo C., Rodriguez-Arias M., Minarro J. Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1263-1271.
57. Shippenberg T.S., Heidbreder C. Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 1995, 273:808-815.
58. Spanagel R. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 1995, 70:37-49.
59. Ungless M.A., Whistler J.L., Malenka R.C., Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001, 411:583-587.
60. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
61. Viganò D., Rubino T., Di Chiara G., Ascari I., Massi P., Parolaro D. Mu opioid receptor signaling in morphine sensitization. Neuroscience 2003, 117:921-929.
62. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998, 54:679-720.
63. Yim T.T., Hong N.S., Ejaredar M., McKenna J.E., McDonald R.J. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience 2008, 151:929-936.
64. Zarrindast M.R., Farahmandfar M., Rostami P., Rezayof A. The influence of central administration of dopaminergic and cholinergic agents on morphine-induced amnesia in morphine-sensitized mice. J Psychopharmacol 2006, 20:59-66.
65. Zarrindast M.R., Farajzadeh Z., Rostami P., Rezayof A., Nourjah P. Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats. Behav Brain Res 2005, 163:100-106.
66. Zarrindast M.R., Hoghooghi V., Rezayof A. Inhibition of morphine-induced amnesia in morphine-sensitized mice: involvement of dorsal hippocampal GABAergic receptors. Neuropharmacology 2008, 54:569-576.
67. Zimmer A., Valjent E., Konig M., Zimmer A.M., Robledo P., Hahn H., et al. Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurosci 2001, 21:9499-9505.